Krishna C. Bulusu

DeepSynergy: predicting anti-cancer drug synergy with Deep Learning

Kristina Preuer, Richard P. Lewis, Sepp Hochreiter et al. · Bioinformatics · 2017 · 677 citations · Full text

Pharmacy, Bioinformatics, Pharmacology +16

Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen

Michael P. Menden, Dennis Wang, Mike J. Mason et al. · Nature Communications · 2019 · 363 citations · Full text

Medicine, Oncology, Pharmacology +16

Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial

Juliann Chmielecki, Tony Mok, Yi‐Long Wu et al. · Nature Communications · 2023 · 173 citations · Full text

Medicine, Oncology, Pharmacology +17

Development of a Novel Azaspirane That Targets the Janus Kinase-Signal Transducer and Activator of Transcription (STAT) Pathway in Hepatocellular Carcinoma in Vitro and in Vivo

Chakrabhavi Dhananjaya Mohan, Hanumantharayappa Bharathkumar, Krishna C. Bulusu et al. · Journal of Biological Chemistry · 2014 · 159 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Knowledge graph-based recommendation framework identifies drivers of resistance in EGFR mutant non-small cell lung cancer

Anna Gogleva, Dimitris Polychronopoulos, Matthias Pfeifer et al. · Nature Communications · 2022 · 94 citations · Full text

Medicine, Bioinformatics, Oncology +16